Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Perdue

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Cancer Research|December 1, 1988
Insulin-like growth factor II mRNA expression in human breast cancerD Yee, K J Cullen, S Paik, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysisT Enjoh, N Hizuka, J F Perdue, et al.
The Journal of Biological Chemistry|January 25, 1971
Studies on the characterization of the sodium-potassium transport adenosine triphosphatase. VI. Large scale partial purification and properties of a lubrol-solubilized bovine brain enzymeS Uesugi, N C Dulak, J F Dixon, et al.
The Journal of Biological Chemistry|November 5, 1991
The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptorK Sakano, T Enjoh, F Numata, et al.
The Journal of Biological Chemistry|July 28, 1995
N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functionsR Hashimoto, H Fujiwara, N Higashihashi, et al.
Stem Cells (Dayton, Ohio)|May 1, 1996
Comparative effects of insulin-like growth factor II (IGF-II) and IGF-II mutants specific for IGF-II/CIM6-P or IGF-I receptors on in vitro hematopoiesisG N Schwartz, M K Warren, K Sakano, et al.
The Journal of Clinical Investigation|June 11, 1992
Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomographyR C Eastman, R E Carson, D G Orloff, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Cancer Research|December 1, 1988
Insulin-like growth factor II mRNA expression in human breast cancerD Yee, K J Cullen, S Paik, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysisT Enjoh, N Hizuka, J F Perdue, et al.
The Journal of Biological Chemistry|January 25, 1971
Studies on the characterization of the sodium-potassium transport adenosine triphosphatase. VI. Large scale partial purification and properties of a lubrol-solubilized bovine brain enzymeS Uesugi, N C Dulak, J F Dixon, et al.
The Journal of Biological Chemistry|November 5, 1991
The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptorK Sakano, T Enjoh, F Numata, et al.
The Journal of Biological Chemistry|July 28, 1995
N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functionsR Hashimoto, H Fujiwara, N Higashihashi, et al.
Stem Cells (Dayton, Ohio)|May 1, 1996
Comparative effects of insulin-like growth factor II (IGF-II) and IGF-II mutants specific for IGF-II/CIM6-P or IGF-I receptors on in vitro hematopoiesisG N Schwartz, M K Warren, K Sakano, et al.
The Journal of Clinical Investigation|June 11, 1992
Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomographyR C Eastman, R E Carson, D G Orloff, et al.
Pageof 6